Market Overview:
Spatial Genomics analyzes the spatial organization and gene expression at single cell resolution within their in situ context and three-dimensional microenvironment. It has advantages over traditional genomic methods as it facilitates exploration of cell types and microenvironments within tissues.
The global Spatial Genomics Market is estimated to be valued at US$ 262.7 Mn or Million in 2023 and is expected to exhibit a CAGR of 13.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the spatial genomics market is the technological advancements in spatial transcriptomics techniques. Researchers are working on improving resolution, throughput, and cost of spatial genomics techniques. For instance, expansion microscopy has enabled expansion of biological tissues to 50-100 times, allowing higher resolution imaging. Emergence of in situ sequencing techniques has boosted the applications of spatial genomics in studying gene expression patterns, cell organization, and cell-cell interactions at single cell resolution within their native tissue microenvironments.
Segment Analysis
The global spatial genomics transcriptomics market is dominated by the spatial transcriptomics segment owing to its wide applications in various research areas such as oncology, immunology, and neuroscience. Spatial transcriptomics help in studying gene expression at a single-cell resolution combined with the spatial context of the cells in their original tissue environment.
Key Takeaways
The global spatial genomics transcriptomics market is expected to witness high growth, exhibiting a CAGR of 13.% over the forecast period, due to increasing funding by government organizations and private entities for spatially resolved genomic and transcriptomic analysis technologies.
Regional analysis
North America dominated the global market in 2022 owing to increasing funding for precision medicine based research in the region. Asia Pacific is expected to witness the fastest growth over the forecast period due to growing healthcare expenditure and rising adoption of advanced technologies for research in countries such as China and India.
Key players
Key players operating in the spatial genomics transcriptomics market are 10x Genomics, NanoString Technologies, Illumina, Fluidigm Corporation, PerkinElmer, Akoya Biosciences (formerly known as CytoViva), Spatial Transcriptomics, Dovetail Genomics (Part of Illumina), S2 Genomics, Visiopharm, MGI Tech Co. Ltd., CARTANA, RareCyte, Horizon Discovery Group, and IONpath. 10x Genomics is the dominant player owing to its robust portfolio of spatial genomics and transcriptomics consumables and instruments.
No comments:
Post a Comment